JPS55153712A - Insulin pharmaceutical preparation and its production - Google Patents
Insulin pharmaceutical preparation and its productionInfo
- Publication number
- JPS55153712A JPS55153712A JP6129279A JP6129279A JPS55153712A JP S55153712 A JPS55153712 A JP S55153712A JP 6129279 A JP6129279 A JP 6129279A JP 6129279 A JP6129279 A JP 6129279A JP S55153712 A JPS55153712 A JP S55153712A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- insulin
- pharmaceutical preparation
- excipien
- tunica mucosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PURPOSE: An insulin pharmaceutical preparation capable of remedying diafetes, effective in a small amount, readily absorbable through the tunica mucosa especially in the form of a supporsitory or sublingual tablet, obtained by adding a specific acid to insulin and an excipien for preparing a drug absorbable through the tunica mucosa.
CONSTITUTION: Insulin and an excipien for preparing a drug absorbable through the tunica mucosa are blended with an acid, e.g, a 1W6C lower saturated fatty acid, lower aliphthatic oxycarboxylic acid, hydrochloric acid, phosphoric acid, benzoic acid, phthalic acid, monochloroacetic acid, acrylic acid, pyrubic acid, to give an insulin pharmaceutical preparation. The amount of the acid is 0.01W0.5wt%, preferably 0.02W0.1wt% based on the total composition. The addition of a protease inhibitor continues the effect of insulin. Insulin is dissolved in an aqueous acid solution, to which the excipien is added to give the insulin pharmaceutical preparation. By this method the absorption effect is improved. Effective in an amount of one-scores of insulin in a conventional suppository.
COPYRIGHT: (C)1980,JPO&Japio
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6129279A JPS55153712A (en) | 1979-05-18 | 1979-05-18 | Insulin pharmaceutical preparation and its production |
FR8010946A FR2456522A1 (en) | 1979-05-18 | 1980-05-14 | Insulin compsns. for admin via mucosa - contg. selected acids to increase absorption pref. also contg. a surfactant and a protease inhibitor |
DE19803018843 DE3018843A1 (en) | 1979-05-18 | 1980-05-16 | INSULIN PREPARATION AND METHOD FOR PRODUCING THE SAME |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6129279A JPS55153712A (en) | 1979-05-18 | 1979-05-18 | Insulin pharmaceutical preparation and its production |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55153712A true JPS55153712A (en) | 1980-11-29 |
JPS5643443B2 JPS5643443B2 (en) | 1981-10-13 |
Family
ID=13166964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6129279A Granted JPS55153712A (en) | 1979-05-18 | 1979-05-18 | Insulin pharmaceutical preparation and its production |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS55153712A (en) |
DE (1) | DE3018843A1 (en) |
FR (1) | FR2456522A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56138112A (en) * | 1980-03-31 | 1981-10-28 | Teijin Ltd | Suppository containing ascorbic acid or sodium ascorbate |
JPS56138115A (en) * | 1980-03-31 | 1981-10-28 | Teijin Ltd | Suppository containing acidic amino acid or derivative thereof |
JPS56138110A (en) * | 1980-03-28 | 1981-10-28 | Teijin Ltd | Suppository containing citric acid or salt thereof |
JPS5780315A (en) * | 1980-11-09 | 1982-05-19 | Kyoto Yakuhin Kogyo Kk | Absorption promotor for accelerating rectum absorption, base comprising it, and pharmaceutical preparation to be medicated to rectum |
JPS5838210A (en) * | 1981-08-31 | 1983-03-05 | Taiho Yakuhin Kogyo Kk | Preparation for rectal administration |
JPS60197618A (en) * | 1984-03-19 | 1985-10-07 | Taiyo Kagaku Kk | Medicinal composition for suppository |
JPS62158207A (en) * | 1986-01-06 | 1987-07-14 | Showa Yakuhin Kako Kk | Composition for rectal administration |
US7635675B2 (en) | 2003-08-13 | 2009-12-22 | Biocon Limited | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6321704Y2 (en) * | 1981-06-02 | 1988-06-15 | ||
SU1011126A1 (en) * | 1981-07-14 | 1983-04-15 | Всесоюзный научно-исследовательский и испытательный институт медицинской техники | Method of treating diabetes mellitus |
JPS61138863A (en) * | 1984-12-11 | 1986-06-26 | Honda Motor Co Ltd | Engine body of internal-conbustion engine |
DE3532074A1 (en) * | 1985-09-09 | 1987-03-12 | Berlin Chemie Veb | RESORPTION AGENT FOR BIOLOGICALLY ACTIVE PEPTIDES |
JPH048302Y2 (en) * | 1985-10-22 | 1992-03-03 | ||
AU618517B2 (en) * | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
US5059587A (en) * | 1987-08-03 | 1991-10-22 | Toyo Jozo Company, Ltd. | Physiologically active peptide composition for nasal administration |
NZ228285A (en) * | 1988-03-11 | 1991-08-27 | Teikoku Seiyaku Kk | Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration |
CA2050425A1 (en) * | 1990-09-03 | 1992-03-04 | Yoshiaki Uda | Pharmaceutical composition and its mucous use |
DE10114178A1 (en) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinc-free and low-zinc insulin preparations with improved stability |
US20030017181A1 (en) | 2001-05-31 | 2003-01-23 | Rood Gloria A. | Dermatological compositions and methods |
DE10227232A1 (en) | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Sour insulin preparations with improved stability |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
MXPA05004278A (en) | 2002-10-25 | 2005-10-05 | Foamix Ltd | Cosmetic and pharmaceutical foam. |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20070292355A1 (en) * | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
RS56632B1 (en) | 2008-10-17 | 2018-03-30 | Sanofi Aventis Deutschland | Combination of an insulin and a glp-1 agonist |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
CA2776366C (en) | 2009-10-02 | 2017-07-18 | Foamix Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
ES2855146T3 (en) | 2009-11-13 | 2021-09-23 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine |
PT3345593T (en) | 2009-11-13 | 2023-11-27 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising despro36exendin-4(1-39)-lys6-nh2 and methionine |
HUE031181T2 (en) | 2010-08-30 | 2017-06-28 | Sanofi Aventis Deutschland | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
CN103917241A (en) | 2011-08-29 | 2014-07-09 | 赛诺菲-安万特德国有限公司 | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
AR087744A1 (en) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE |
JP6970615B2 (en) | 2014-12-12 | 2021-11-24 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Insulin glargine / lixisenatide fixed ratio prescription |
TWI748945B (en) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | Treatment type 2 diabetes mellitus patients |
TW201705975A (en) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | Treatment of type 2 diabetes mellitus patients |
MX2017011630A (en) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Compositions and methods for treating rosacea and acne. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL45481C (en) * | 1900-01-01 | |||
JPS5315412A (en) * | 1976-07-27 | 1978-02-13 | Ono Pharmaceut Co Ltd | Suppository for diabetics |
GB2051574B (en) * | 1979-05-10 | 1984-01-18 | Kyoto Pharma Ind | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
-
1979
- 1979-05-18 JP JP6129279A patent/JPS55153712A/en active Granted
-
1980
- 1980-05-14 FR FR8010946A patent/FR2456522A1/en not_active Withdrawn
- 1980-05-16 DE DE19803018843 patent/DE3018843A1/en not_active Withdrawn
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56138110A (en) * | 1980-03-28 | 1981-10-28 | Teijin Ltd | Suppository containing citric acid or salt thereof |
JPS56138112A (en) * | 1980-03-31 | 1981-10-28 | Teijin Ltd | Suppository containing ascorbic acid or sodium ascorbate |
JPS56138115A (en) * | 1980-03-31 | 1981-10-28 | Teijin Ltd | Suppository containing acidic amino acid or derivative thereof |
JPS631923B2 (en) * | 1980-03-31 | 1988-01-14 | Teijin Ltd | |
JPH0242809B2 (en) * | 1980-03-31 | 1990-09-26 | ||
JPS5780315A (en) * | 1980-11-09 | 1982-05-19 | Kyoto Yakuhin Kogyo Kk | Absorption promotor for accelerating rectum absorption, base comprising it, and pharmaceutical preparation to be medicated to rectum |
JPS5838210A (en) * | 1981-08-31 | 1983-03-05 | Taiho Yakuhin Kogyo Kk | Preparation for rectal administration |
JPH0136442B2 (en) * | 1981-08-31 | 1989-07-31 | Taiho Pharmaceutical Co Ltd | |
JPS60197618A (en) * | 1984-03-19 | 1985-10-07 | Taiyo Kagaku Kk | Medicinal composition for suppository |
JPS62158207A (en) * | 1986-01-06 | 1987-07-14 | Showa Yakuhin Kako Kk | Composition for rectal administration |
JPH0521895B2 (en) * | 1986-01-06 | 1993-03-25 | Showa Pharm Chem Ind | |
US7635675B2 (en) | 2003-08-13 | 2009-12-22 | Biocon Limited | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents |
Also Published As
Publication number | Publication date |
---|---|
JPS5643443B2 (en) | 1981-10-13 |
DE3018843A1 (en) | 1980-11-20 |
FR2456522A1 (en) | 1980-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS55153712A (en) | Insulin pharmaceutical preparation and its production | |
JPS53109555A (en) | Preparation of modified keratin-containing material | |
JPS5350141A (en) | Stabilization of prostaglandin and prostaglandin analogues | |
JPS5350316A (en) | Drug composition for oral administration | |
JPS5214745A (en) | Preparation of phenylcarbamic acid esters | |
JPS52806A (en) | Preparation of ester | |
JPS5661311A (en) | Thial amide or prolonged pharmaceutical preparation comprising its salt | |
JPS5231024A (en) | Process for preparation of epoxysuccinic acid esters | |
JPS549240A (en) | New derivative of phenylglycolic acid, its preparation and analgesic and antiinflammatory agent contining it as effective component | |
JPS5283428A (en) | Preparation of aromatic carboxylic acid amide derivatives | |
JPS55122715A (en) | Antidiabetic agent | |
JPS57193473A (en) | Vitamin e linoleic acid ester | |
JPS5612309A (en) | Oral drug containing ubidecarenone | |
JPS5242815A (en) | Process for preparation of carboxylic acid esters | |
JPS5283412A (en) | Preparation of 3,3-dimethyl-4-pentenoic acids | |
ES483463A1 (en) | 1-Methyl-4-piperidinol esters of 4-quinolinylamino benzoates and antiinflammatory and analgesic compositions and methods employing them | |
JPS5283411A (en) | Preparation of 3,3-dimethyl-4-pentenoic acid and its derivatives | |
JPS57106644A (en) | Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation | |
JPS536414A (en) | Carboxylic acid aluminum salts and their preparation | |
JPS5318586A (en) | Preparation of 5-fluorouracils | |
JPS52111587A (en) | Preparation of 6-aminopenam carboxylic acid-1-oxide or its derivatives | |
JPS5283413A (en) | Preparation of 3,3-dimethyl-4-pentenoic acid or its esters | |
JPS5365867A (en) | Preparation of chenodeoxycholic acid crystal | |
JPS5246013A (en) | Process for preparation of gamma-unsaturated carboxylic acid esters | |
JPS5328161A (en) | Preparation of 3-amino-1-benzylpyrrolidine derivatives |